| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.0005 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.098 | 0.0009 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.084 | 0.003 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.099 | 0.003 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.084 | 0.004 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.089 | 0.005 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.007 |